FDA evidence for full approval of COVID antiviral Paxlovid, known for “rebound” infections in top federal officials, found wanting by scientists, including NIAID researcher.
FDA evidence for full approval of COVID antiviral Paxlovid, known for “rebound” infections in top federal officials, found wanting by scientists, including NIAID researcher.